ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins - PubMed (original) (raw)
ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
Nan Wang et al. Proc Natl Acad Sci U S A. 2004.
Abstract
The mechanisms responsible for the inverse relationship between plasma high-density lipoprotein (HDL) levels and atherosclerotic cardiovascular disease are poorly understood. The ATP-binding cassette transporter A1 (ABCA1) mediates efflux of cellular cholesterol to lipid-poor apolipoproteins but not to HDL particles that constitute the bulk of plasma HDL. We show that two ABC transporters of unknown function, ABCG1 and ABCG4, mediate isotopic and net mass efflux of cellular cholesterol to HDL. In transfected 293 cells, ABCG1 and ABCG4 stimulate cholesterol efflux to both smaller (HDL-3) and larger (HDL-2) subclasses but not to lipid-poor apoA-I. Treatment of macrophages with an liver X receptor activator results in up-regulation of ABCG1 and increases cholesterol efflux to HDL. RNA interference reduced the expression of ABCG1 in liver X receptor-activated macrophages and caused a parallel decrease in cholesterol efflux to HDL. These studies indicate that ABCG1 and ABCG4 promote cholesterol efflux from cells to HDL. ABCG1 is highly expressed in macrophages and probably mediates cholesterol efflux from macrophage foam cells to the major HDL fractions, providing a mechanism to explain the relationship between HDL levels and atherosclerosis risk.
Figures
Fig. 1.
LXR/RXR activation increases macrophage cholesterol efflux to HDL independent of ABCA1. (A and B) Cholesterol efflux to apoA-I (15 μg/ml protein) (A) or HDL-2 (25 μg/ml protein) (B) was determined in mouse peritoneal macrophages isolated from WT or ABCA1-/- mice. The cells were labeled with [3H]cholesterol in cell culture media plus 10% FBS for 16 h and then treated with or without 5 μM TO901317 plus 5 μM 9-_cis_-retinoic acid for 16 h followed by cholesterol efflux for 4 h.
Fig. 2.
Cells transfected with ABCG1 and ABCG4 cDNAs show increased cholesterol efflux to HDL. HEK293 cells were transiently transfected with plasmid constructs expressing ABCG transporters or control empty vector (mock), and cholesterol efflux was initiated by addition of HDL to media. (A) [3H]cholesterol efflux to HDL-2 or HDL-3 (25 μg/ml HDL protein) or media alone (control) for 4 h. (B) [3H]Cholesterol efflux to HDL-2 (25 μg/ml HDL protein) for 4 h. (C) [3H]Cholesterol efflux to HDL-2 at indicated concentrations for 4 h. (D)[3H]Cholesterol efflux to HDL-2 (25 μg/ml HDL protein) for the indicated period of time.
Fig. 3.
ABCG1 and ABCG4 expression increase cholesterol mass efflux to HDL and decrease cellular cholesterol content. (A) Free cholesterol mass in culture media determined in transfected 293 cells incubated with HDL-2 (25 μg/ml HDL protein) for 4 h. (B) Total cellular cholesterol was determined after 6 h incubation of transfected 293 cells with HDL-2 (25 μg/ml HDL protein).
Fig. 4.
ABCG1 and ABCG4 do not promote cholesterol efflux to apoA-I and do not bind HDL while promoting cholesterol efflux to HDL, LDL, and cyclodextrin. (A) HDL-2 (25 μg/ml HDL protein) and apoA-I (15 μg/ml protein) mediated cholesterol efflux during a 4-h incubation with 293 cells expressing ABCG transporters. (B) [3H]choline-containing phospholipid efflux to HDL-2 (25 μg/ml HDL protein) during a 4-h incubation with 293 cells expressing ABCG transporters. (C) Cholesterol efflux to HDL (25 μg/ml HDL protein), LDL (25 μg/ml LDL protein), or cyclodextrin (1 mM) during a 4-h incubation with 293 cells expressing ABCG transporters. (D) [125I]HDL binding to 293 cells expressing SR-BI or ABCG transporters.
Fig. 5.
Suppression of ABCG1 expression by RNAi decreases macrophage cholesterol efflux to HDL. [3H]cholesterol efflux to HDL-2 was determined by using mouse peritoneal macrophages after transfection of the cells with synthetic siRNA against ABCG1 (A and B). Two different concentrations of siRNA were used, as indicated. As a control, scrambled siRNA or siRNA against ABCA7 were used. mRNA levels of ABCG1 (B) normalized against β-actin mRNA from macrophages treated with 120 nM siRNA were determined by TaqMan real-time RT-PCR. *, P < 0.05; **, P < 0.01.
Similar articles
- ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain.
Wang N, Yvan-Charvet L, Lütjohann D, Mulder M, Vanmierlo T, Kim TW, Tall AR. Wang N, et al. FASEB J. 2008 Apr;22(4):1073-82. doi: 10.1096/fj.07-9944com. Epub 2007 Nov 26. FASEB J. 2008. PMID: 18039927 - LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL.
Wang N, Ranalletta M, Matsuura F, Peng F, Tall AR. Wang N, et al. Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1310-6. doi: 10.1161/01.ATV.0000218998.75963.02. Epub 2006 Mar 23. Arterioscler Thromb Vasc Biol. 2006. PMID: 16556852 - HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM, Kim MJ, Hou L, Le Goff W, Chapman MJ, Van Eck M, Curtiss LK, Burnett JR, Cartland SP, Quinn CM, Kockx M, Kontush A, Rye KA, Kritharides L, Jessup W. Du XM, et al. Circ Res. 2015 Mar 27;116(7):1133-42. doi: 10.1161/CIRCRESAHA.116.305485. Epub 2015 Jan 14. Circ Res. 2015. PMID: 25589556 - Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
Cavelier C, Lorenzi I, Rohrer L, von Eckardstein A. Cavelier C, et al. Biochim Biophys Acta. 2006 Jul;1761(7):655-66. doi: 10.1016/j.bbalip.2006.04.012. Epub 2006 May 4. Biochim Biophys Acta. 2006. PMID: 16798073 Review. - ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.
Ye D, Lammers B, Zhao Y, Meurs I, Van Berkel TJ, Van Eck M. Ye D, et al. Curr Drug Targets. 2011 May;12(5):647-60. doi: 10.2174/138945011795378522. Curr Drug Targets. 2011. PMID: 21039336 Review.
Cited by
- Mutagenesis on a complex mouse genetic background by site-specific nucleases.
Davies B, Trelfa L, Rashbrook VS, Drydale E, Martin R, Bai B, Golebka J, Biggs DS, Channon KM, Bhattacharya S, Douglas G. Davies B, et al. Transgenic Res. 2024 Aug 1. doi: 10.1007/s11248-024-00399-5. Online ahead of print. Transgenic Res. 2024. PMID: 39088185 - LncRNA DANCR promotes macrophage lipid accumulation through modulation of membrane cholesterol transporters.
Zhao GJ, Wang Y, An JH, Tang WY, Xu XD, Ren K. Zhao GJ, et al. Aging (Albany NY). 2024 Jul 2;16(18):12510-12524. doi: 10.18632/aging.205992. Epub 2024 Jul 2. Aging (Albany NY). 2024. PMID: 38968577 Free PMC article. - Monocyte-to-high-density lipoprotein cholesterol ratio and the risk of erectile dysfunction: a study from NHANES 2001-2004.
Wu X, Zhang Y, Jiang H, Zhang X. Wu X, et al. Sex Med. 2024 May 6;12(2):qfae025. doi: 10.1093/sexmed/qfae025. eCollection 2024 Apr. Sex Med. 2024. PMID: 38715577 Free PMC article. - Molecular Pathways of Vulnerable Carotid Plaques at Risk of Ischemic Stroke: A Narrative Review.
Miceli G, Basso MG, Pintus C, Pennacchio AR, Cocciola E, Cuffaro M, Profita M, Rizzo G, Tuttolomondo A. Miceli G, et al. Int J Mol Sci. 2024 Apr 15;25(8):4351. doi: 10.3390/ijms25084351. Int J Mol Sci. 2024. PMID: 38673936 Free PMC article. Review. - Behavioral and Metabolic Effects of ABCG4 KO in the APPswe,Ind (J9) Mouse Model of Alzheimer's Disease.
Fong V, Kanuri B, Traubert O, Lui M, Patel SB. Fong V, et al. J Mol Neurosci. 2024 Apr 26;74(2):49. doi: 10.1007/s12031-024-02214-6. J Mol Neurosci. 2024. PMID: 38668787 Free PMC article.
References
- Orso, E., Broccardo, C., Kaminski, W. E., Bottcher, A., Liebisch, G., Drobnik, W., Gotz, A., Chambenoit, O., Diederich, W., Langmann, T., et al. (2000) Nat. Genet. 24, 192-196. - PubMed
- Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J. C., Deleuze, J. F., Brewer, H. B., Duverger, N., Denefle, P., et al. (1999) Nat. Genet. 22, 352-355. - PubMed
- Bodzioch, M., Orso, E., Klucken, J., Langmann, T., Bottcher, A., Diederich, W., Drobnik, W., Barlage, S., Buchler, C., Porsch-Ozcurumez, M., et al. (1999) Nat. Genet. 22, 347-351. - PubMed
- Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L. H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O., et al. (1999) Nat. Genet. 22, 336-345. - PubMed
- Wang, N., Silver, D. L., Costet, P. & Tall, A. R. (2000) J. Biol. Chem. 275, 33053-33058. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases